| Clinically meaningful improvement in prevalence achieved (≥10%)? | Desired prevalence (≥80%) achieved? | ||||
---|---|---|---|---|---|---|
Yes (n = 10) | No (n = 31) |  | Yes (n = 2) | No (n = 39) |  | |
Variable | Average for sites grouped by outcomes (%) | |||||
Baseline prevalence | 47 | 58 | Â | 68 | 54 | Â |
12-month prevalence | 63 | 58 | Â | 84 | 58 | Â |
Change in prevalence over 12 months | 16 | 0 |  | 17 | 3 |  |
Implementation Strategy | Proportion that implemented each strategy (%) | |||||
 |  |  | p valuea |  |  | p valuea |
Key contact engagement (attendance at both education and QI planning meeting) | 70 | 55 | 0.4 | 100 | 56 | 0.5 |
Provided additional staff education | 10 | 3 | 0.4 | 0 | 5 | ~ 1 |
Provided resident education | 50 | 52 | ~ 1 | 100 | 49 | 0.4 |
Provided family education | 20 | 23 | ~ 1 | 50 | 21 | 0.3 |
Emailed families information | 0 | 36 | 0.04 | 50 | 26 | 0.4 |
Made information available onsite | 0 | 48 | 0.006 | 0 | 39 | 0.5 |
Added vitamin D to staff meeting agendas | 30 | 23 | 0.6 | 50 | 23 | 0.4 |
Staff education uploaded into online portals | 20 | 10 | 0.5 | 0 | 13 | ~ 1 |
Completed audit to identify residents for vitamin D | 70 | 42 | 0.15 | 100 | 46 | 0.2 |
Implemented a local process to identify residents | 60 | 36 | 0.2 | 100 | 39 | 0.16 |
General follow up with GPs | 10 | 45 | 0.06 | 0 | 39 | 0.5 |
Follow up with GPs regarding individual residents | 60 | 26 | 0.06 | 100 | 31 | 0.11 |
General follow up with pharmacists | 30 | 29 | ~ 1 | 0 | 31 | ~ 1 |